PMID- 17030177 OWN - NLM STAT- MEDLINE DCOM- 20061204 LR - 20220409 IS - 0016-5085 (Print) IS - 1528-0012 (Electronic) IS - 0016-5085 (Linking) VI - 131 IP - 4 DP - 2006 Oct TI - Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. PG - 1064-72 AB - BACKGROUND & AIMS: Two advanced cytologic techniques for detecting aneuploidy-digital image analysis (DIA) and fluorescence in situ hybridization (FISH)-have recently been developed to help identify malignant pancreatobiliary strictures. The aim of this study was to assess the clinical utility of cytology, DIA, and FISH for the identification of malignant pancreatobiliary strictures. METHODS: Brush cytologic specimens from 233 consecutive patients undergoing endoscopic retrograde cholangiopancreatography for pancreatobiliary strictures were examined by all 3 (cytology, DIA, and FISH) techniques. Strictures were stratified as proximal (n = 33) or distal (n = 114) based on whether they occurred above or below the cystic duct, respectively. Strictures in patients with primary sclerosing cholangitis (n = 86) were analyzed separately. RESULTS: Despite the stratification, the performances of the tests were similar. Conventional cytology has a low sensitivity (4%-20%) but 100% specificity. Because of the high specificity for cytology, we assessed the performance of the other tests when conventional cytology was negative. In this clinical context, FISH had an increased sensitivity (35%-60%) when assessing for chromosomal gains (polysomy) while preserving the specificity of cytology. The sensitivity and specificity of DIA was intermediate as compared with routine cytology and FISH but was additive to FISH values demonstrating only trisomy of chromosome 7 or chromosome 3. CONCLUSIONS: These findings suggest that FISH and DIA increase the sensitivity for the diagnosis of malignant pancreatobiliary tract strictures over that obtained by conventional cytology while maintaining an acceptable specificity. FAU - Moreno Luna, Laura E AU - Moreno Luna LE AD - Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. FAU - Kipp, Benjamin AU - Kipp B FAU - Halling, Kevin C AU - Halling KC FAU - Sebo, Thomas J AU - Sebo TJ FAU - Kremers, Walter K AU - Kremers WK FAU - Roberts, Lewis R AU - Roberts LR FAU - Barr Fritcher, Emily G AU - Barr Fritcher EG FAU - Levy, Michael J AU - Levy MJ FAU - Gores, Gregory J AU - Gores GJ LA - eng GR - R01 DK059427/DK/NIDDK NIH HHS/United States GR - NIH 59427/PHS HHS/United States PT - Clinical Trial PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060816 PL - United States TA - Gastroenterology JT - Gastroenterology JID - 0374630 RN - 0 (DNA, Neoplasm) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Aneuploidy MH - Child MH - *Cholangiopancreatography, Endoscopic Retrograde MH - Cholestasis, Extrahepatic/etiology/*pathology MH - Constriction, Pathologic MH - DNA, Neoplasm/analysis MH - Decision Trees MH - Diagnosis, Computer-Assisted MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence/instrumentation/*methods MH - Male MH - Middle Aged MH - Pancreatic Neoplasms/complications/*pathology MH - Predictive Value of Tests MH - Sensitivity and Specificity PMC - PMC1769444 MID - NIHMS14109 EDAT- 2006/10/13 09:00 MHDA- 2006/12/09 09:00 PMCR- 2008/01/30 CRDT- 2006/10/13 09:00 PHST- 2006/04/06 00:00 [received] PHST- 2006/07/05 00:00 [accepted] PHST- 2006/10/13 09:00 [pubmed] PHST- 2006/12/09 09:00 [medline] PHST- 2006/10/13 09:00 [entrez] PHST- 2008/01/30 00:00 [pmc-release] AID - S0016-5085(06)01760-4 [pii] AID - 10.1053/j.gastro.2006.08.021 [doi] PST - ppublish SO - Gastroenterology. 2006 Oct;131(4):1064-72. doi: 10.1053/j.gastro.2006.08.021. Epub 2006 Aug 16.